Millennium Management’s Boundless Bio BOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$110K Sell
99,875
-35,535
-26% -$41.6K ﹤0.01% 5324
2025
Q4
$162K Sell
135,410
-28,681
-17% -$35.7K ﹤0.01% 5529
2025
Q3
$202K Sell
164,091
-49,470
-23% -$57.1K ﹤0.01% 5546
2025
Q2
$216K Buy
+213,561
New +$284K ﹤0.01% 5331
2024
Q3
Sell
-234,663
Closed -$908K 6554
2024
Q2
$908K Buy
234,663
+111,313
+90% +$1.06M ﹤0.01% 4165
2024
Q1
$1.76M Buy
+123,350
New +$1.76M ﹤0.01% 3856

Other funds holding BOLD

Millennium Management's BOLD Position: Q1 2026 in Review

Millennium Management reduced its Boundless Bio (BOLD) stake by 26% in Q1 2026, selling an estimated $41.6K and leaving 99,875 shares worth $110K. The position accounts for ﹤0.01% of the portfolio, ranked #5324.

Millennium Management first reported a position in BOLD in Q1 2024 and has held it in 6 quarters since. The position peaked at $1.76M in Q1 2024. 36 funds tracked by Wall St. Rank hold BOLD as of Q1 2026.

  • Millennium Management held 99,875 shares of Boundless Bio worth $110K as of Q1 2026.
  • Millennium Management sold 35,535 Boundless Bio shares in Q1 2026, an estimated $41.6K.
  • Boundless Bio made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #5324 holding.
  • Millennium Management first reported a position in Boundless Bio in Q1 2024 and has held it in 6 quarters since.
  • Millennium Management's Boundless Bio position peaked at $1.76M in Q1 2024.
  • 36 funds tracked by Wall St. Rank held Boundless Bio as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.